Spero Therapeutics paid its 3 named executives $5.5M in total in FY2025 (Dec). CEO Esther Rajavelu was paid $2.1M of that.
Pay$100 in the stock at the end of FY22 → $135
Pay of each named executive
Esther RajaveluPresident and Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Satyavrat ShuklaFormer President and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Timothy KeutzerChief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.